1. Home
  2. PRVA vs APGE Comparison

PRVA vs APGE Comparison

Compare PRVA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$22.35

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$82.68

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRVA
APGE
Founded
2007
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
4.7B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
PRVA
APGE
Price
$22.35
$82.68
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$31.17
$109.67
AVG Volume (30 Days)
994.8K
557.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
N/A
EPS
0.02
N/A
Revenue
$2,122,842,000.00
N/A
Revenue This Year
$18.19
N/A
Revenue Next Year
$10.72
N/A
P/E Ratio
$1,139.00
N/A
Revenue Growth
22.26
N/A
52 Week Low
$18.78
$34.34
52 Week High
$26.51
$95.32

Technical Indicators

Market Signals
Indicator
PRVA
APGE
Relative Strength Index (RSI) 40.56 51.46
Support Level $21.47 $80.52
Resistance Level $24.74 $86.42
Average True Range (ATR) 0.90 3.92
MACD -0.17 -0.17
Stochastic Oscillator 28.13 62.12

Price Performance

Historical Comparison
PRVA
APGE

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: